By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Roche Molecular Diagnostics, Inc. 

4300 Hacienda Drive

Pleasanton  California  94588  U.S.A.
Phone: 925-730-8000 Fax: 925-225-0479


Roche Molecular Diagnostics (operating in the US as Roche Molecular Systems) develops, manufactures and supplies a wide array of innovative medical diagnostic products, services, tests, platforms and technologies. With its broad portfolio of oncology, virology, microbiology and blood screening tests, RMD’s clients include researchers, physicians, patients, hospitals, laboratories and blood banks around the world.

The business, headquartered in Pleasanton, California, was founded in the early 1990s following the acquisition of the revolutionary, Nobel-prize winning Polymerase Chain Reaction Technology (PCR). PCR quickly replicates a single specific fragment of DNA or RNA to quantities sufficient for accurate laboratory analysis.

Roche Molecular Diagnostics employs around around 1,400 people across five locations: Pleasanton, California; Los Gatos, California; Branchburg, New Jersey; Marlborough, Massachusetts; and Rotkreuz, Switzerland.

Centers of Excellence for Roche Molecular Systems

Branchburg (US): The largest polymerase chain reaction (PCR) manufacturing site in the world, supply chain, global customer support and quality

Los Gatos (US): Newest location that focuses on microbiology diagnostics

Marlborough (US): Center for RMD’s Point of Care business

Pleasanton (US): Headquarters, R&D, regulatory, clinical and medical affairs, business marketing and strategic marketing support

Rotkreuz (CH): Development and production of systems (instruments) and lab network solutions (software)

Key Statistics

Ownership: Subsidiary

Web Site: Roche Molecular Diagnostics
Employees: Approximately 1,100
Symbol: RHHBF.PK

Company News
Genticel To Evaluate Roche Molecular Systems (RHHBF.PK)’ cobas HPV Test In Preparation For PhIII Program Of GTL001 1/7/2016 8:32:03 AM
Illumina (ILMN) Files New Patent Infringement Suit Against Ariosa Diagnostics, Inc. And Roche Molecular Systems, Inc. (RHHBF.PK) 5/19/2015 11:21:01 AM
Roche Molecular Systems, Inc. (RHHBF.PK) Wins FDA Approval For First Ever Pap Alternative To Detect Cervical Cancer 4/24/2014 2:26:37 PM
AdvanDx, Inc. Elects Former Roche Molecular Systems, Inc. (RHHBF.PK) CEO, Heiner Dreismann, Ph.D., to Its Board of Directors 3/27/2013 10:58:50 AM
Roche Molecular Systems, Inc. (RHHBF.PK) Launches Redesigned Website 12/9/2011 5:00:11 PM
Roche Molecular Systems, Inc. (RHHBF.PK) Release: Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark 12/9/2011 4:48:28 PM
Roche Molecular Systems, Inc. (RHHBF.PK) Release: Companion Diagnostic Test That Identifies Patients With Melanoma Tumor Mutation Available in Europe 12/9/2011 4:41:54 PM
ATHENA Data Presented at International Papillomavirus Conference Support Use of Roche Molecular Systems (RHHBF.PK)’s cobas HPV Test in Primary Screening for Cervical Cancer 12/9/2011 4:40:13 PM
Roche (RHHBY)'s KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark 7/22/2011 7:47:01 AM
Pivotal Study Validates Roche (RHHBY)'s cobas(R) HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer 2/25/2011 7:38:31 AM